Kiran Mazumdar-Shaw joins US Pharmacopeial Convention's board of trustees

The US Pharmacopeial Convention has named Biocon chairman, managing director founder Kiran Mazumdar-Shaw to its board of trustees.

Shaw becomes the second non-US member of the USP board of trustees.

Biotech founder and a biotechnology entrepreneur with global standing, Shaw will help guide USP's policies, finances and strategic direction. She will serve as a member of the USP Biologics Advisory Group.

USP develops standards for the identity, strength, quality and purity of medicines, medicinal ingredients, botanical medicinal ingredients, dietary supplements, food ingredients, and compounded medicines manufactured, prepared, distributed and consumed worldwide.

Headquartered in the United States, USP operates facilities with laboratory and customer support operations in Brazil, India and China, with a sales office in Switzerland.

''As a businesswoman, public health advocate and philanthropist, Kiran Mazumdar-Shaw has innovated and campaigned tirelessly for affordable medications on behalf of patients in India and worldwide for decades,'' said Dr. Roger L. Williams, chief executive officer of USP in a statement.

''We are honoured to have her serve on USP's board of trustees, where her leadership and expertise will be utilised to help guide the organisation as it advances its mission to improve the health of people around the world through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.''